Search Result "NF-κB p65"
When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3263-3275
Author(s): Zhao-Hui Wu, Yuling Shi
Medicinal Plants in Cancer Treatment: Contribution of Nuclear Factor-Kappa B (NF-kB) Inhibitors
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 22 Issue: 15 Year: 2022 Page: 1938-1962
Author(s): Dinesh Kumar Mehta
Nifedipine Inhibits the Progression of An Experimentally Induced Cerebral Aneurysm in Rats with Associated Down-Regulation of NF-Kappa B Transcriptional Activity
Journal: Current Neurovascular Research
Volume: 5 Issue: 1 Year: 2008 Page: 37-45
Author(s): Tomohiro Aoki, Hiroharu Kataoka, Ryota Ishibashi, Kazuhiko Nozaki, Nobuo Hashimoto
Analysis of Inhibition Potential of Nimbin and its Analogs against NF-κB Subunitsp50 and p65: A Molecular Docking and Molecular Dynamics Study
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 24 Issue: 4 Year: 2024 Page: 280-287
Author(s): Deepshikha Pande Katare
Suppression of Erosive Arthritis by NF-κB Inhibitors
Journal: Current Rheumatology Reviews
Volume: 7 Issue: 4 Year: 2011 Page: 275-281
Author(s): Tetsuo Kubota, Kazuo Umezawa
NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 4 Year: 2017 Page: 483-490
Author(s): Maria LetÃcia de Castro Barbosa,Raissa Alves da Conceicao,Aline Guerra Manssour Fraga,Barbara Dias Camarinha,Gabriela Cristina de Carvalho Silva,Antonio Gilcler Ferreira Lima,Elisama Azevedo Cardoso,Viviane de Oliveira Freitas Lione
Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis
Journal: Current Cancer Drug Targets
Volume: 7 Issue: 4 Year: 2007 Page: 325-334
Author(s): S. J. Cooper, G. T. Bowden
Targeting of NF-kappaB Signaling Pathway, other Signaling Pathways and Epigenetics in Therapy of Multiple Myeloma
Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 13 Issue: 1 Year: 2013 Page: 16-34
Author(s): Ota Fuchs
Direct Covalent Modification as a Strategy to Inhibit Nuclear Factor-Kappa B
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4261-4273
Author(s): V. Pande, S. F. Sousa, M. J. Ramos
Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in OralSquamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase1A2 (ALDH1A2)
Journal: Current Cancer Drug Targets
Volume: 22 Issue: 9 Year: 2022 Page: 771-783
Author(s):